Empowering people, informing care decisions.

At Castle, it all comes down to people. After all, disease doesn’t just happen — it happens to people. We believe that disease management and treatment decisions can be better informed through a person’s unique biology, which is revealed through the scientific rigor of our innovative tests. We are committed to empowering healthcare providers and patients with the goal of improved outcomes.

About Us

Clinical focus areas

Our broad portfolio of innovative tests focuses on answering critical clinical questions. From individualized risk of melanoma metastasis to customized medication profiles for mental health conditions, our tests are designed to deliver personalized information that better informs care decisions.

Navigate to Dermatology

Dermatology

Navigate to Gastroenterology

Gastroenterology

Navigate to Mental Health

Mental Health

Navigate to Ophthalmology

Ophthalmology

An active older man is outside at sunrise and looking into the distance

Our tests

Cutaneous Melanoma

Make more confident, more accurate treatment plan decisions for sentinel lymph node biopsy guidance as well as surveillance and therapeutic interventions.

Make more confident, more accurate diagnostic decisions with genomic insight for melanocytic lesions.

A happy older man fishes with his son

Cutaneous Squamous Cell Carcinoma (SCC)

Make more confident, more accurate treatment plan decisions for surveillance and therapeutic interventions.

An older man walks his dog on a trail

Barrett’s Esophagus

Go beyond tissue morphology to predict a patient’s individualized risk of progression to esophageal cancer in Barrett’s esophagus.

An assured woman with cropped hair, looks directly at the camera

Mental Health

Comprehensive pharmacogenomic (PGx) testing that guides personalized mental health medication selection, tailored to each patient's unique profile.

A smiling older woman leans against a wall

Uveal Melanoma

Make more informed, risk-aligned treatment plan decisions based on comprehensive molecular profiling.

Relentless pursuit of the best outcomes

At Castle, we combine innovation, advanced technologies and relevant real-world evidence to address critical unmet clinical needs and improve health outcomes.

Castle’s tests have been studied in more than 20,000 patients and their validity and utility have been demonstrated in more than 130 peer-reviewed publications.

The latest

News

Press Release
Conference icon

Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum

Press Release
Conference icon

Castle Biosciences to Present New Data Highlighting the Clinical Value of its Dermatologic Tests for Patien...

Press Release
Conference icon

In Novel Cohort, New Data Confirms DecisionDx®-SCC Provides Significant, Independent and Clinically Actiona...

We are transforming disease management. Join in the transformation.

Every employee at Castle has an impact on patient care. If you are interested in making a difference in the lives of patients while doing something that inspires you, find out what exciting opportunities are available within our team.

A rotating image. Image 1 A woman is pleased as she looks at a computer screen Image 2 A woman engaged happily with someone across a table from her Image 3 A clinician looks down at a tablet